Literature DB >> 1313215

Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization.

J A Barberà1, S Hayashi, R G Hegele, J C Hogg.   

Abstract

The involvement of Epstein-Barr virus (EBV) in the pathogenesis of lymphocytic interstitial pneumonia (LIP) was investigated using an in situ hybridization technique. Archival lung tissue samples from 14 patients (six men and eight women with a mean age of 58 +/- 3 yr) in whom a diagnosis of LIP had been previously established were retrospectively examined and compared with samples from 10 patients (six men and four women with a mean age of 58 +/- 3 yr) with idiopathic pulmonary fibrosis (IPF) who served as control subjects. In patients with LIP, the immunophenotype of the lymphocytic infiltrate was determined by using monoclonal antibodies to both pan-B-cell and pan-T-cell markers. In situ hybridization studies were performed by using the BamHI-W region of the EBV genome as a probe and a colorimetric detection method. The immunophenotyping studies showed that the interstitial infiltrate in LIP was primarily made up of B-lymphocytes, particularly within the lymphoid aggregates, whereas T-lymphocytes were sparsely distributed along the alveolar septa. The in situ hybridization studies showed the presence of cells bearing the EBV genome in nine cases of LIP and in two cases of IPF (p less than 0.05, Fisher's exact test). In LIP, the EBV-positive cells were observed in both enlarged and normal septa and occasionally within the lymphoid aggregates. We conclude that EBV may promote the proliferation of B-lymphocytes in a substantial number of patients with LIP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313215     DOI: 10.1164/ajrccm/145.4_Pt_1.940

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  18 in total

Review 1.  Non-neoplastic pulmonary lymphoid lesions.

Authors:  W D Travis; J R Galvin
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.

Authors:  H Jenson; K McIntosh; J Pitt; S Husak; M Tan; Y Bryson; K Easley; W Shearer
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

3.  Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient.

Authors:  Andi Krumbholz; Tim Sandhaus; Angela Göhlert; Albert Heim; Roland Zell; Renate Egerer; Martin Breuer; Eberhard Straube; Peter Wutzler; Andreas Sauerbrei
Journal:  Med Microbiol Immunol       Date:  2010-07-20       Impact factor: 3.402

4.  Epstein-Barr virus and cryptogenic fibrosing alveolitis.

Authors:  J C Hogg
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

5.  Does an Epstein-Barr viral infection influence the pathogenesis of a primary pulmonary B-cell lymphoma?

Authors:  A Tamura; M Kitagawa; H Komatsu; R Takano; J Wakimoto; J Homma; A Nagase; E Nemoto; N Yanai
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 6.  Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.

Authors:  Paul J Maglione
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 7.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

8.  Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.

Authors:  Hal B. Jenson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

Review 9.  Challenges in pulmonary fibrosis. 3: Cystic lung disease.

Authors:  Gregory P Cosgrove; Stephen K Frankel; Kevin K Brown
Journal:  Thorax       Date:  2007-09       Impact factor: 9.139

10.  Lymphocytic interstitial pneumonitis in HIV infected adults.

Authors:  S Das; R F Miller
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.